MENU
AMPH
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Amphastar Pharmaceuticals (AMPH) Earnings Date & Reports

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products... Show more

A.I. Advisor
published Earnings

AMPH is expected to report earnings to fall 2.91% to 71 cents per share on August 11

Amphastar Pharmaceuticals AMPH Stock Earnings Reports
Q2'25
Est.
$0.72
Q1'25
Beat
by $0.05
Q4'24
Missed
by $0.05
Q3'24
Missed
by $0.04
Q2'24
Beat
by $0.17
The last earnings report on May 07 showed earnings per share of 74 cents, beating the estimate of 68 cents. With 510.68K shares outstanding, the current market capitalization sits at 2.11B.
View a ticker or compare two or three
AMPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of proprietary injectable and inhalation products

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
11570 6th Street
Phone
+1 909 980-9484
Employees
1761
Web
https://www.amphastar.com